Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
NCT06969404

Prognostic Value of Capillary Lactatemia in Potentially Severe Polytrauma Patients

Led by Centre Hospitalier Universitaire de Nice · Updated on 2026-03-30

550

Participants Needed

3

Research Sites

96 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Nowadays, the tools available to assess the severity of a polytrauma patient in the pre-hospital setting (vital parameters, shock index, MGAP score, Vittel criteria) have their limitations and are sometimes subjective. To date, there are no objective, practical and reproducible tools for triaging these patients. Venous lactataemia also appears to be predictive of poor outcome in severe trauma. However, there are no studies in the literature on capillary lactataemia, which would indicate the potential severity of a polytrauma patient in the pre-hospital setting. However, it is an easily performed, risk-free assay, the results of which can be obtained rapidly at the scene of the accident. The aim of this project is to confirm that, like venous lactataemia, capillary lactataemia can be useful in the pre-hospital phase for predicting a patient's poor outcome. Incorporating this assay into the assessment of potentially severe polytrauma patients in the pre-hospital phase could improve the predictive value of clinical and contextual data and thus enable better referral and management of these patients.

CONDITIONS

Official Title

Prognostic Value of Capillary Lactatemia in Potentially Severe Polytrauma Patients

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patient over 18 years of age
  • Presenting a potentially serious pre-hospital trauma defined by a road accident or a fall of more than 2 metres
  • Requiring the dispatch of a SMUR 06 mobile emergency and resuscitation team
  • Transferred to an emergency facility in the Alpes Maritimes with medical assistance
  • Consent signed by the patient or a relative after the event if immediate signing is not possible
  • Pregnant women may participate without risk to themselves or their child
Not Eligible

You will not qualify if you...

  • Patients with isolated peripheral limb trauma (wrist, elbow, knee, ankle, shoulder)
  • Patients under legal protection (guardianship, curatorship)
  • Patients in cardiorespiratory arrest when taken into care by the SMUR emergency medical services

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 3 locations

1

Antibes Hospital

Antibes, France, 06400

Not Yet Recruiting

2

Cannes hospital

Cannes, France, 06000

Not Yet Recruiting

3

Nice University Hospital

Nice, France, 06000

Actively Recruiting

Loading map...

Research Team

M

Marta FERNANDES FEIRRERA, PH

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

OTHER

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here